Jyothy Labs Ltd. announces a capital-allocation move
TL;DR
Based on the Letter of Offer, what is the total cash outflow for the buyback, and how does this impact the company's net cash position relative to the cash and cash equivalents reported in the most recent quarterly balance sheet?
The buyback consideration is up to ₹147 Cr: 61.25 lakh shares at ₹240 per share under the revised terms. The Letter of Offer amount excludes transaction costs and taxes, so the all-in cash outflow would be marginally higher than ₹147 Cr. [1] [2]
Against approximately ₹846 Cr of cash and cash equivalents and zero debt reported for Q2 FY27, the buyback would consume about 17.4% of available cash (₹147 Cr ÷ ₹846 Cr, derived). [3]
Assuming the buyback is funded entirely from existing cash, with no intervening cash generation or borrowing:
- Pre-buyback net cash: approximately ₹846 Cr
- Less: buyback consideration: ₹147 Cr
- Post-buyback net cash: approximately ₹699 Cr, before transaction costs and taxes
Thus, the buyback reduces net cash by roughly ₹147 Cr, but does not make the company net-debt-funded on the reported balance-sheet figures; residual net cash would remain approximately ₹699 Cr before the additional costs of the offer.
What is the stated intent of the promoter and promoter group regarding participation in this tender offer, and how does this compare to their shareholding activity in the open market over the preceding four quarters?
The promoter and promoter group stated that they would not participate in Jyothy Labs’ tender-offer buyback [3]. This is broadly consistent with their ownership pattern: aggregate promoter holding did not decline or increase over the four quarters reviewed.
Comparison: Over Q3 FY26–Q2 FY27, the promoter stake remained unchanged at 62.89%, including through the quarter in which the largest holder-level changes occurred. The Q3 movements appear to have been an internal change in the registered promoter holders rather than a change in total promoter ownership.
The important qualification is that the quarterly shareholding pattern does not separately report open-market trade execution. Therefore, it supports the conclusion of no net change in promoter ownership, but it cannot establish that promoters made no individual open-market purchases or sales. The available evidence is nevertheless consistent with the stated intention not to tender shares into the buyback.
| Quarter | Promoter holding | Recorded promoter-group activity | Analyst read |
|---|---|---|---|
| Q3 FY26 | 62.89% | M. G. Shanthakumari exited 39.12%; the M. P. Ramachandran Family Trust II entered with 39.12%; M. P. Ramachandran also exited 1.75% | Holder-level restructuring, but no aggregate change |
| Q4 FY26 | 62.89% | No promoter holding change recorded | No net accumulation or disposal |
| Q1 FY27 | 62.89% | No promoter holding change recorded | No net accumulation or disposal |
| Q2 FY27 | 62.89% | No promoter holding change recorded | No net accumulation or disposal |
How does the buyback price per share compare to the company's current TTM P/E valuation, and how does the total buyback size as a percentage of net worth align with the capital allocation policies of mid-cap FMCG peers?
The buyback price of ₹240 is 22.2% above Jyothy Labs’ latest close of ₹196.33 on 13 November 2026. Holding TTM EPS constant, the buyback price therefore corresponds to 1.22 times the company’s current market-price P/E. However, the absolute current TTM P/E cannot be confirmed because TTM EPS or TTM PAT for Jyothy Labs is not reported in the cited financial data.
Buyback valuation
The offer price is therefore a premium tender price rather than a price that can be described as a discount to the current valuation. The company’s absolute TTM P/E still requires a verified TTM EPS denominator.
Net-worth and peer capital-allocation comparison
A net-worth comparison cannot be completed reliably: Jyothy Labs’ net worth or total equity for the relevant period is not reported in the cited data. Consequently, ₹147 Cr divided by net worth cannot be calculated without substituting an unsupported denominator.
The peer evidence is also insufficient to establish a policy benchmark:
Analyst read: Jyothy Labs’ disclosed buyback scale is 1.67% of outstanding equity and approximately 2.0% of market capitalisation, but its percentage of net worth is not established. The peer set does not provide disclosed buyback or payout policies against which to classify Jyothy Labs’ action as conservative, aggressive or peer-aligned. Also, the comparison is not fully like-for-like because Kokuyo Camlin is represented on a standalone basis while the other peers are consolidated.
| Metric | Calculation / outcome | Interpretation |
|---|---|---|
| Buyback price | ₹240 per share [4] | Tender price |
| Latest market price | ₹196.33 on 13 November 2026 | Exchange-reported latest close |
| Premium to market price | 22.2%, derived from ₹240 and ₹196.33 | Buyback is priced materially above the prevailing market price |
| Relative P/E at buyback price | 1.22x current market-price P/E, derived from ₹240 / ₹196.33 | If current P/E were 30.0x, the buyback price would imply 36.7x; this is an illustration, not Jyothy Labs’ reported P/E |
| Shares repurchased | Up to 61.25 lakh, or 1.67% of equity capital [1] | Moderate share-count reduction |
| Buyback outgo | Up to ₹147 Cr [4] | Equivalent to approximately 2.0% of the ₹7,210 Cr market capitalisation, derived |
| Peer | Reported total equity, Q2 FY27 | Buyback or capital-allocation policy |
|---|---|---|
| Flair Writing Industries | ₹1,196.3 Cr, consolidated [5] | Not disclosed; could not be confirmed for FY26–FY27 |
| Eveready Industries | ₹676.3 Cr, consolidated [6] | Not disclosed; could not be confirmed for FY26–FY27 |
| DOMS Industries | ₹1,283.4 Cr, consolidated [7] | Not disclosed; could not be confirmed for FY26–FY27 |
| Kokuyo Camlin | ₹328.5 Cr, standalone [8] | Not disclosed; could not be confirmed for FY26–FY27 |
| Linc | ₹258.6 Cr, consolidated [9] | Not disclosed; could not be confirmed for FY26–FY27 |
Sources
- [1]Jyothy Labs hikes buyback price to ₹240, cuts share repurchase target to 61 lakh - CNBC TV18 — CNBC TV18, 2026-11-09T00:00:00
- [2]1£\ — Jyothylabs, 2026-11-04T00:00:00
- [3]Earnings call transcript: Jyothy Labs Q2 2027 profit slumps as costs bite By Investing.com — Investing.com, 2026-10-31T00:00:00
- [4]Jyothy Labs Announces Offer Opening for Share Buyback via Tender Offer — 2026-11-14T14:55:19.537000, p.4
- [5]Total Equity
- [6]Total Equity
- [7]Total Equity
- [8]Total Equity
- [9]Total Equity
Keep digging